An Updated Overview of Polycystic Ovary Syndrome

    Kanchan Choudhary, Ranjan Kumar Singh, Ajay Garg, Nitesh Verma, Anjali Purohit, Deepika Deora
    Image of study
    TLDR Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.
    The 2019 document provided an overview of Polycystic Ovary Syndrome (PCOS), a hormonal disorder affecting 5-10% of women of reproductive age. PCOS is characterized by menstrual dysfunction, hyperandrogenism, obesity, acne, amenorrhea, irregular menstrual cycles, hirsutism, insulin resistance, and high cholesterol. It can lead to infertility due to ovulation issues. The disorder is believed to be a result of interactions between genetic and environmental factors, with obesity exacerbating the underlying genetic predisposition. The treatment for PCOS can involve lifestyle changes, synthetic medicine, and alternative medicine. The document also highlighted the role of insulin resistance in the pathogenesis of PCOS and suggested that interventions that improve insulin sensitivity may ameliorate hyperandrogenism in women with PCOS. The study involved 52 women and found that women with PCOS were more likely to report hirsutism, diabetes mellitus, hypertension, and previous coronary artery disease. The study also found that androgenic alopecia is common in women with PCOS, but requires a familial predisposition to baldness and an associated increase in circulating androgens. The document concluded by emphasizing the need for more research into the genetics and pathophysiology of PCOS to determine preventative risk factors and successful treatment modalities.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  444 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    3 / 3 results